Association of MST1 in the First Trimester of Pregnancy with Gestational Diabetes Mellitus and Adverse Pregnancy Outcomes

References

• Modzelewski R, Stefanowicz-Rutkowska MM, Matuszewski W, Bandurska-Stankiewicz EM. Gestational diabetes mellitus-recent literature review. J Clin Med. 2022;11(19):19. doi:10.3390/jcm11195736
   Web of Science ®Google Scholar
• Dalfra MG, Burlina S, Del Vescovo GG, Lapolla A. Genetics and epigenetics: new insight on gestational diabetes mellitus. Front Endocrinol. 2020;11:602477. doi:10.3389/fendo.2020.602477
   PubMed Web of Science ®Google Scholar
• Zhang Y, Xiao CM, Zhang Y, et al. Factors associated with gestational diabetes mellitus: a meta-analysis. J Diabetes Res. 2021;2021:6692695. doi:10.1155/2021/6692695
   PubMedGoogle Scholar
• Plows JF, Stanley JL, Baker PN, Reynolds CM, Vickers MH. The pathophysiology of gestational diabetes mellitus. Int J Mol Sci. 2018;19(11):3342. doi:10.3390/ijms19113342
   PubMed Web of Science ®Google Scholar
• Sweeting AN, Ross GP, Hyett J, et al. Gestational diabetes mellitus in early pregnancy: evidence for poor pregnancy outcomes despite treatment. Diabetes Care. 2016;39(1):75–81. doi:10.2337/dc15-0433
   PubMed Web of Science ®Google Scholar
• Vounzoulaki E, Khunti K, Abner SC, Tan BK, Davies MJ, Gillies CL. Progression to type 2 diabetes in women with a known history of gestational diabetes: systematic review and meta-analysis. BMJ. 2020;369:m1361. doi:10.1136/bmj.m1361
   PubMed Web of Science ®Google Scholar
• Holt RI. The hyperglycemia and adverse pregnancy outcomes trial: answers but still more questions about the management of gestational diabetes. Diabet Med. 2008;25(9):1013–1014. doi:10.1111/j.1464-5491.2008.02559.x
   PubMed Web of Science ®Google Scholar
• Liu B, Cai J, Xu Y, et al. Early diagnosed gestational diabetes mellitus is associated with adverse pregnancy outcomes: a prospective cohort study. J Clin Endocrinol Metab. 2020;105(12):e4264–e4274. doi:10.1210/clinem/dgaa633
   Web of Science ®Google Scholar
• Gunderson EP, Sun B, Catov JM, et al. Gestational diabetes history and glucose tolerance after pregnancy associated with coronary artery calcium in women during midlife: the CARDIA study. Circulation. 2021;143(10):974–987. doi:10.1161/CIRCULATIONAHA.120.047320
   PubMed Web of Science ®Google Scholar
• Bianco ME, Josefson JL. Hyperglycemia during pregnancy and long-term offspring outcomes. Curr Diab Rep. 2019;19(12):143. doi:10.1007/s11892-019-1267-6
   PubMed Web of Science ®Google Scholar
• Ye W, Luo C, Huang J, Li C, Liu Z, Liu F. Gestational diabetes mellitus and adverse pregnancy outcomes: systematic review and meta-analysis. BMJ. 2022;377:e067946. doi:10.1136/bmj-2021-067946
   PubMedGoogle Scholar
• Fajans SS, Bell GI, Polonsky KS. Molecular mechanisms and clinical pathophysiology of maturity-onset diabetes of the young. N Engl J Med. 2001;345(13):971–980. doi:10.1056/NEJMra002168
   PubMed Web of Science ®Google Scholar
• Pombo CM, Iglesias C, Sartages M, Zalvide JB. MST kinases and metabolism. Endocrinology. 2019;160(5):1111–1118. doi:10.1210/en.2018-00898
   PubMed Web of Science ®Google Scholar
• Ardestani A, Paroni F, Azizi Z, et al. MST1 is a key regulator of beta cell apoptosis and dysfunction in diabetes. Nat Med. 2014;20(4):385–397. doi:10.1038/nm.3482
   PubMed Web of Science ®Google Scholar
• Ardestani A, Maedler K. MST1: a promising therapeutic target to restore functional beta cell mass in diabetes. Diabetologia. 2016;59(9):1843–1849. doi:10.1007/s00125-016-3892-9
   PubMed Web of Science ®Google Scholar
• López Stewart G. Diagnostic criteria and classification of hyperglycaemia first detected in pregnancy: a World Health Organization Guideline. Diabet Res Clin Pract. 2014;103(3):341–363. doi:10.1016/j.diabres.2013.10.012
   PubMed Web of Science ®Google Scholar
• Law KP, Zhang H. The pathogenesis and pathophysiology of gestational diabetes mellitus: deductions from a three-part longitudinal metabolomics study in China. Clin Chim Acta. 2017;468:60–70. doi:10.1016/j.cca.2017.02.008
   PubMed Web of Science ®Google Scholar
• Cefalu WT, Berg EG, Petersen MP, Darsow T. American Diabetes Association’s Standards of Care: a paradigm shift in the dissemination of information. Diabetes Care. 2018;41(3):387–388. doi:10.2337/dci17-0064
   PubMed Web of Science ®Google Scholar
• Lowe WL, Scholtens DM, Kuang A, et al.; Group, H. F.-u. S. C. R. Hyperglycemia and Adverse Pregnancy Outcome Follow-up Study (HAPO FUS): maternal gestational diabetes mellitus and childhood glucose metabolism. Diabetes Care. 2019;42(3):372–380. doi:10.2337/dc18-1646
   PubMed Web of Science ®Google Scholar
• Johns EC, Denison FC, Norman JE, Reynolds RM. Gestational diabetes mellitus: mechanisms, treatment, and complications. Trends Endocrinol Metab. 2018;29(11):743–754. doi:10.1016/j.tem.2018.09.004
   PubMed Web of Science ®Google Scholar
• Bi W, Xiao L, Jia Y, et al. c-Jun N-terminal kinase enhances MST1-mediated pro-apoptotic signaling through phosphorylation at serine 82. J Biol Chem. 2010;285(9):6259–6264. doi:10.1074/jbc.M109.038570
   PubMed Web of Science ®Google Scholar
• Cheung W, Ajiro K, Samejima K, et al. Apoptotic phosphorylation of histone H2B is mediated by mammalian sterile twenty kinase. Cell. 2003;113(4):507–517. doi:10.1016/s0092-8674(03)00355-6
   PubMed Web of Science ®Google Scholar
• Yu J, Zhai X, Li X, et al. Identification of MST1 as a potential early detection biomarker for colorectal cancer through a proteomic approach. Sci Rep. 2017;7(1):14265. doi:10.1038/s41598-017-14539-x
   PubMed Web of Science ®Google Scholar
• Shi Y, Liu B, Wang C, Yang C. MST1 down-regulation in decreasing apoptosis of aortic dissection smooth muscle cell apoptosis. Eur Rev Med Pharmacol Sci 2018;22(7):2044–2051. doi:10.26355/eurrev_201804_14734
   PubMed Web of Science ®Google Scholar
• Tian C, Qiu M, Lv H, Yue F, Zhou F. Quantitative proteomic analysis of serum reveals MST1 as a potential candidate biomarker in spontaneously diabetic cynomolgus monkeys. ACS omega. 2022;7(50):46702–46716. doi:10.1021/acsomega.2c05663
   PubMed Web of Science ®Google Scholar
• Galan JA, Avruch J. MST1/MST2 protein kinases: regulation and physiologic roles. Biochemistry. 2016;55(39):5507–5519. doi:10.1021/acs.biochem.6b00763
   PubMed Web of Science ®Google Scholar
• Ardestani A, Maedler K. MST1 deletion protects beta-cells in a mouse model of diabetes. Nutr Diabetes. 2022;12(1):7. doi:10.1038/s41387-022-00186-3
   PubMed Web of Science ®Google Scholar
• Gao T, Zhou D, Yang C, et al. Hippo signaling regulates differentiation and maintenance in the exocrine pancreas. Gastroenterology. 2013;144(7):1543–1553, 1553 e1. doi:10.1053/j.gastro.2013.02.037
   PubMedGoogle Scholar
• Wu Y, Qi Z, Wang B, et al. Discovery of IHMT-MST1-58 as a novel, potent, and selective MST1 inhibitor for the treatment of type 1/2 diabetes. J Med Chem. 2022;65(17):11818–11839. doi:10.1021/acs.jmedchem.2c00926
   PubMed Web of Science ®Google Scholar
• Angelis V, Johnston S, Ardestani A, Maedler K. Case report: neratinib therapy improves glycemic control in a patient with type 2 diabetes and breast cancer. Front Endocrinol. 2022;13:830097. doi:10.3389/fendo.2022.830097
   PubMed Web of Science ®Google Scholar
• Kuhl C. Insulin secretion and insulin resistance in pregnancy and GDM. Implications for diagnosis and management. Diabetes. 1991;40(Suppl 2):18–24. doi:10.2337/diab.40.2.S18
   PubMed Web of Science ®Google Scholar
• Landon MB, Gabbe SG. Gestational diabetes mellitus. Obstet Gynecol. 2011;118(6):1379–1393. doi:10.1097/AOG.0b013e31823974e2
   PubMed Web of Science ®Google Scholar
• Liu R, Wei C, Ma Q, Wang W. Hippo-YAP1 signaling pathway and severe preeclampsia (sPE) in the Chinese population. Pregnancy Hypertens. 2020;19:1–10. doi:10.1016/j.preghy.2019.11.002
   PubMed Web of Science ®Google Scholar
• Sharma J, Madan P. Characterisation of the Hippo signalling pathway during bovine preimplantation embryo development. Reprod Fertil Dev. 2020;32(4):392–401. doi:10.1071/RD18320
   PubMed Web of Science ®Google Scholar
• Oh S, Lee D, Kim T, et al. Crucial role for Mst1 and Mst2 kinases in early embryonic development of the mouse. Mol Cell Biol. 2009;29(23):6309–6320. doi:10.1128/MCB.00551-09
   PubMed Web of Science ®Google Scholar
• Sun X, Ren Z, Cun Y, et al. Hippo-YAP signaling controls lineage differentiation of mouse embryonic stem cells through modulating the formation of super-enhancers. Nucleic Acids Res. 2020;48(13):7182–7196. doi:10.1093/nar/gkaa482
   PubMed Web of Science ®Google Scholar